Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Mager

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Arzneimittel-Forschung|August 1, 1975
[MASCA-model of the biochemical-pharmacological drug research. Part 2: Multivariate test criterions and methods (author's transl)]P P Mager
Medicinal Research Reviews|June 19, 2001
The active site of HIV-1 proteaseP P Mager
Arzneimittel-Forschung|November 1, 1975
[MASCA-model of the biochemical-pharmacological drug research / part 5: Structure-activity relationships and MACOVA (author's transl)]P P Mager
Pharmazie in Unserer Zeit|September 1, 1988
[Optimization of the bioactive lead structure. II. Verification of the system]P P Mager
Activitas Nervosa Superior|May 1, 1975
The discrimination in time series analysis - a working procedureP P Mager
Tierarztliche Praxis|January 1, 1976
[Classification of drug side-effects]P P Mager
Drug Design and Discovery|April 1, 1994
Interactive multivariate modelling of 4-amino-2-carboxytetrahydroquinolines as antagonists of the glycine-site directed NMDA receptor-ion channel complexP P Mager
Activitas Nervosa Superior|March 1, 1983
Indirect discrimination of type 1 mu and 1 delta opioid receptor properties using quantitative structure-activity relationshipsP P Mager
Gegenbaurs Morphologisches Jahrbuch|January 1, 1980
Structure-activity relationships of interactions of thyroxine analogs with intact hepatic nucleic receptorsP P Mager
Drug Design and Discovery|December 1, 1996
Molecular simulation of the folding patterns of the omega-loop (Tyr181 to Tyr188) of HIV-1 reverse transcriptaseP P Mager
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Arzneimittel-Forschung|August 1, 1975
[MASCA-model of the biochemical-pharmacological drug research. Part 2: Multivariate test criterions and methods (author's transl)]P P Mager
Medicinal Research Reviews|June 19, 2001
The active site of HIV-1 proteaseP P Mager
Arzneimittel-Forschung|November 1, 1975
[MASCA-model of the biochemical-pharmacological drug research / part 5: Structure-activity relationships and MACOVA (author's transl)]P P Mager
Pharmazie in Unserer Zeit|September 1, 1988
[Optimization of the bioactive lead structure. II. Verification of the system]P P Mager
Activitas Nervosa Superior|May 1, 1975
The discrimination in time series analysis - a working procedureP P Mager
Tierarztliche Praxis|January 1, 1976
[Classification of drug side-effects]P P Mager
Drug Design and Discovery|April 1, 1994
Interactive multivariate modelling of 4-amino-2-carboxytetrahydroquinolines as antagonists of the glycine-site directed NMDA receptor-ion channel complexP P Mager
Activitas Nervosa Superior|March 1, 1983
Indirect discrimination of type 1 mu and 1 delta opioid receptor properties using quantitative structure-activity relationshipsP P Mager
Gegenbaurs Morphologisches Jahrbuch|January 1, 1980
Structure-activity relationships of interactions of thyroxine analogs with intact hepatic nucleic receptorsP P Mager
Drug Design and Discovery|December 1, 1996
Molecular simulation of the folding patterns of the omega-loop (Tyr181 to Tyr188) of HIV-1 reverse transcriptaseP P Mager
Pageof 11